Validation of the Artificial Pancreas Diabeloop Algorithm in the Hospital
Status:
Completed
Trial end date:
2015-02-01
Target enrollment:
Participant gender:
Summary
To assess whether the DIABELOOP algorithm provides better glycemic control than the usual
algorithm of T1D patients on pump therapy:
- at meals, with CHO roughly assessed by the patient.
- during and after physical activity sessions qualified as moderate by the patient.
Primary endpoint : time within the glycemic reference range. The study will be conduct with
15 patients at the following investigation centers : Corbeil Hospital, CHU of Grenoble, and
CHU of Montpellier.
Phase:
Phase 2/Phase 3
Details
Lead Sponsor:
Centre d'Etudes et de Recherche pour l'Intensification du Traitement du Diabète Centre d’Etudes et de Recherche pour l’Intensification du Traitement du Diabète